ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2687

Clinicopathologic Associations in a Large International Cohort of Patients with Giant Cell Arteritis

Michael Putman1, K Bates Gribbons 2, Anthea Craven 3, Cristina Ponte 4, Joanna Robson 5, Ravi Suppiah 6, Richard Watts 7, Raashid Luqmani 3, Peter Merkel 8, Amy Archer 9 and Peter C. Grayson 10, 1Northwestern University, Chicago, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3University of Oxford, Oxford, United Kingdom, 4Department of Rheumatology, Hospital de Santa Maria, Lisbon, Portugal, 5Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 6Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 7Norwich Medical School, University of East Anglia, Norwich, United Kingdom, 8University of Pennsylvania, Pennsylvania, 9Northwestern, Chicago, 10National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: 18FDG PET/CT scan, Doppler ultrasound and large vessel vasculitis, giant cell arteritis, pathology

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In addition to aiding in diagnosis, histopathologic findings from temporal artery biopsy (TAB) specimens in giant cell arteritis (GCA) may be valuable for their associations with clinical features of the disease.  The study objective was to compare specific histopathologic findings on TAB with biopsy interpretation, demographic, clinical, and imaging features at diagnosis.

Methods: Patients who had a diagnosis of GCA confirmed by expert review were selected from an international, multicenter observational cohort.  Associations between demographic, clinical, radiographic, and histopathologic features were identified using bivariate testing and multivariate regression modeling.

Results: Six hundred forty-seven patients with GCA who underwent TAB were included. Pathology interpretations included definite vasculitis (69%), normal temporal artery biopsy (13%), consistent with vasculitis but not definite (9%), or non-diagnostic (8%).  For 467 biopsies, specific findings were detailed, including the presence of giant cells (63%), fragmentation of the internal elastic lamina (50%), intimal thickening (39%), predominantly mononuclear leukocytes (39%), vascular thrombosis (6%), granuloma (5%), and perivascular inflammation without vessel wall involvement (1%).  In a model that included the common TAB findings ( >10% prevalence), a pathology interpretation of definite vasculitis was independently associated with giant cells (OR 123.4, CI 47.1-323.5), predominantly mononuclear leukocytes (OR 11.8, CI 6.0-23.0), and fragmentation of the internal elastic lamina (OR 4.5, CI 2.4-8.3).  Out of 207 patients who had a temporal artery ultrasound, 166 patients had a halo sign, which was significantly associated with the presence of giant cells (88% vs. 76% without, p=0.04) and intimal thickening (90% vs. 78% without, p = 0.04). Out of 70 patients who underwent PET scanning, no pathologic findings on TAB were associated with PET abnormalities.   Temporal artery abnormalities on exam were associated mononuclear leukocytes (OR 2.01, CI 1.38-2.94).  Older age was associated with the presence of giant cells, fragmentation of the internal elastic lamina, and intimal thickening (see Table 1).  No pathologic findings were associated with vision loss at presentation.

Conclusion: Pathologic findings of temporal artery biopsies in GCA are associated with diagnostic interpretations but not with clinical manifestations of vasculitis. Associations between pathologic findings and imaging abnormalities should be investigated further.

Table 1


Disclosure: M. Putman, None; K. Gribbons, None; A. Craven, None; C. Ponte, None; J. Robson, None; R. Suppiah, None; R. Watts, None; R. Luqmani, Roche, 8, Roche, Vifor, InflaRx, 2; P. Merkel, None; A. Archer, None; P. Grayson, None.

To cite this abstract in AMA style:

Putman M, Gribbons K, Craven A, Ponte C, Robson J, Suppiah R, Watts R, Luqmani R, Merkel P, Archer A, Grayson P. Clinicopathologic Associations in a Large International Cohort of Patients with Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/clinicopathologic-associations-in-a-large-international-cohort-of-patients-with-giant-cell-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinicopathologic-associations-in-a-large-international-cohort-of-patients-with-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology